The top 4 advances in antithrombotic care in the last year Journal Articles

abstract

• Important clinical data with a significant impact on the clinical management of venous thromboembolism (VTE) were presented at The International Society of Thrombosis and Haemostasis (ISTH) meeting, held in Geneva, Switzerland in July of 2007. In addition, 2 new guidelines for the management of patients with acute coronary syndromes (ACS) were published in 2007, and will have a significant impact on daily practice. Finally, the approval of new practice-changing, paradigm-shifting oral anticoagulants is on the horizon. This article will review the top 4 advances in antithrombotic care and discuss their impact on the clinical management of VTE.

authors

• Turpie, Alexander Graham Gri

status

• published 

publication date

• December 2008

has subject area

• 1103 Clinical Sciences (FoR)
• Acute Coronary Syndrome (MeSH)
• Administration, Oral (MeSH)
• Anticoagulants (MeSH)
• Benzimidazoles (MeSH)
• Cardiovascular System & Hematology (Science Metrix)
• Clinical Trials as Topic (MeSH)
• Dabigatran (MeSH)
• Humans (MeSH)
• Morpholines (MeSH)
• Practice Guidelines as Topic (MeSH)
• Pyrazoles (MeSH)
• Pyridines (MeSH)
• Pyridones (MeSH)
• Rivaroxaban (MeSH)
• Thiophenes (MeSH)
• Venous Thromboembolism (MeSH)

published in

• Thrombosis Research  Journal

keywords

• Acute Coronary Syndrome
• Administration, Oral
• Anticoagulants
• Benzimidazoles
• Clinical Trials as Topic
• Dabigatran
• Humans
• Morpholines
• Practice Guidelines as Topic
• Pyrazoles
• Pyridines
• Pyridones
• Rivaroxaban
• Thiophenes
• Venous Thromboembolism

Digital Object Identifier (DOI)

• 10.1016/j.thromres.2008.08.003

PubMed ID

• 18834617

start page

• S2

end page

• S6

volume

• 123

issue

• SUPPL. 1